Featured publications
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
September 10, 2022
Janelidze S, Bali D, Ashton NJ, Barthélemy NR, Vanbrabant J, Stoops E, Vanmechelen E, He Y, Dolado AO, Triana-Baltzer G, Pontecorvo MJ, Zetterberg H, Kolb H, Vandijck M, Blennow K, Bateman RJ, Hansson O. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease. Brain. 2022 Sep 10:awac333. doi: 10.1093/brain/awac333. Epub ahead of print. PMID: 36087307.
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease
February 22, 2022
Budelier MM, He Y, Barthelemy NR, Jiang H, Li Y, Park E, Henson RL, Schindler SE, Holtzman DM, Bateman RJ. A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease. Brain Commun. 2022 Feb 22;4(2):fcac045. doi: 10.1093/braincomms/fcac045. PMID: 35415607; PMCID: PMC8994116.
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
February 15, 2022
Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Shaw LM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. 2022 Feb 15;98(7):e688-e699. doi: 10.1212/WNL.0000000000013211. Epub 2021 Dec 14. PMID: 34906975; PMCID: PMC8865895.
The Informed Road Map to Prevention of Alzheimer Disease: A Call to Arms
July 21, 2021
McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ. The informed road map to prevention of Alzheimer Disease: A call to arms. Mol Neurodegener. 2021 Jul 21;16(1):49. doi: 10.1186/s13024-021-00467-y. PMID: 34289882; PMCID: PMC8293489.
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
March 3, 2021
Horie K, Barthélemy NR, Sato C, Bateman RJ. CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease. Brain. 2021 Mar 3;144(2):515-527. doi: 10.1093/brain/awaa373. Erratum in: Brain. 2021 Oct 22;144(9):e82. PMID: 33283854; PMCID: PMC7940175.
Recent publications
- Lecanemab in Early Alzheimer's Diseasevan Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., Froelich, L., Katayama, S., Sabbagh, M., Vellas, B., Watson, D., Dhadda, S., Irizarry, M., Kramer, L. D. & Iwatsubo, T., Jan 5 2023, In: The New England journal of medicine. 388, 1, p. 9-21 13 p.Research output: Contribution to journal › Article › peer-review
- Biomarker clustering in autosomal dominant Alzheimer's diseasefor the Dominantly Inherited Alzheimer Network (DIAN), Jan 2023, In: Alzheimer's and Dementia. 19, 1, p. 274-284 11 p.Research output: Contribution to journal › Article › peer-review
- Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's diseaseand Dominantly Inherited Alzheimer Network (DIAN), 2023, (Accepted/In press) In: Alzheimer's and Dementia.Research output: Contribution to journal › Article › peer-review
- CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesHorie, K., Barthélemy, N. R., Spina, S., VandeVrede, L., He, Y., Paterson, R. W., Wright, B. A., Day, G. S., Davis, A. A., Karch, C. M., Seeley, W. W., Perrin, R. J., Koppisetti, R. K., Shaikh, F., Lago, A. L., Heuer, H. W., Ghoshal, N., Gabelle, A., Miller, B. L., Boxer, A. L., & 2 othersBateman, R. J. & Sato, C., Dec 2022, In: Nature medicine. 28, 12, p. 2547-2554 8 p.Research output: Contribution to journal › Article › peer-review
- Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s diseaseBateman, R. J., Cummings, J., Schobel, S., Salloway, S., Vellas, B., Boada, M., Black, S. E., Blennow, K., Fontoura, P., Klein, G., Assunção, S. S., Smith, J. & Doody, R. S., Dec 2022, In: Alzheimer's Research and Therapy. 14, 1, 178.Research output: Contribution to journal › Review article › peer-review
- Examining the effects of age and sex on tau PET binding in the absence of beta-amyloid pathologyGordon, B., Flores, S., Dincer, A., Keefe, S. J., McKay, N. S., Hobbs, D. A., Wisch, J. K., Hornbeck, R. C., Franklin, E. E., Jack, C. R., Koeppe, R. A., Xiong, C., McDade, E., van Dyck, C. H., Klein, G., Pariente, J., Bateman, R. J., Morris, J., Perrin, R. J. & Benzinger, T. L. S., Dec 2022, In: Alzheimer's and Dementia. 18, S1, e063285.Research output: Contribution to journal › Comment/debate
- Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyMcDade, E., Cummings, J. L., Dhadda, S., Swanson, C. J., Reyderman, L., Kanekiyo, M., Koyama, A., Irizarry, M., Kramer, L. D. & Bateman, R. J., Dec 2022, In: Alzheimer's Research and Therapy. 14, 1, 191.Research output: Contribution to journal › Article › peer-review
- The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature reviewBrand, A. L., Lawler, P. E., Bollinger, J. G., Li, Y., Schindler, S., Li, M., Lopez, S., Ovod, V., Nakamura, A., Shaw, L. M., Zetterberg, H., Hansson, O. & Bateman, R. J., Dec 2022, In: Alzheimer's Research and Therapy. 14, 1, 195.Research output: Contribution to journal › Review article › peer-review
- Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoringAshton, N. J., Janelidze, S., Mattsson-Carlgren, N., Binette, A. P., Strandberg, O., Brum, W. S., Karikari, T. K., González-Ortiz, F., Di Molfetta, G., Meda, F. J., Jonaitis, E. M., Koscik, R. L., Cody, K., Betthauser, T. J., Li, Y., Vanmechelen, E., Palmqvist, S., Stomrud, E., Bateman, R. J., Zetterberg, H., & 3 othersJohnson, S. C., Blennow, K. & Hansson, O., Dec 2022, In: Nature medicine. 28, 12, p. 2555-2562 8 p.Research output: Contribution to journal › Article › peer-review
- Plasma MCP-1 and changes on cognitive function in community-dwelling older adultsfor the MAPT/DSA Group, Dec 2022, In: Alzheimer's Research and Therapy. 14, 1, 5.Research output: Contribution to journal › Article › peer-review